Progyny (PGNY) Revenue (2018 - 2026)

Progyny (PGNY) has 9 years of Revenue data on file, last reported at $328.5 million in Q1 2026.

• Revenue for Q1 2026 came in at $328.5 million, up 1.38% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.3 billion (up 6.59% YoY), and the FY2025 annual result was $1.3 billion, up 10.4% from the prior year.
• Revenue rose to $328.5 million in Q1 2026 per PGNY's latest filing, from $318.4 million in the prior quarter.
• Over five years, Revenue peaked at $332.9 million in Q2 2025 and troughed at $172.2 million in Q1 2022.
• A 5-year average of $274.1 million and a median of $280.9 million in 2023 frame the typical range for Revenue.
• The sharpest annual moves came in 2022 and 2026: Revenue soared 68.03% in 2022, then rose 1.38% in 2026.
• A 5-year view of Revenue shows it stood at $214.3 million in 2022, then gained by 25.95% to $269.9 million in 2023, then increased by 10.55% to $298.4 million in 2024, then grew by 6.69% to $318.4 million in 2025, then advanced by 3.17% to $328.5 million in 2026.
• Business Quant data shows PGNY's Revenue at $328.5 million in Q1 2026, $318.4 million in Q4 2025, and $313.3 million in Q3 2025.